Lonza nominates Pearl Huang and Lonza Group stock gains 1.23 percent

Published on 10/02/2026 at 17:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Lonza reported CHF 3.4 billion sales in Half-Year 2026. Lonza Group stock costs EUR 606.70 after EUR 599.30, plus 1.23 percent on October 2, 2026.

Schwarz-Weiß-Reportage: Wissenschaftler im Schutzanzug am Mikroskop, dokumentarischer Stil — Lonza CH0013841017 Forscher im Schutzanzug am Mikroskop dokumentarisch in Schwarz Weiss fotografiert, Illustration mit AI erstellt.

Lonza Group (ISIN CH0013841017) was trading at EUR 606.70 at Lang & Schwarz on October 2, 2026 at 5:02 p.m. CEST, up 1.23 percent from the EUR 599.30 prior close of October 1. On September 30, Lonza nominated Pearl Huang as an independent board member, according to Lonza.

Board renewal adds industry expertise

Huang is subject to election at Lonza's annual general meeting in May 2027. If elected, she will join the Strategy and Innovation Committee and the Remuneration Committee, while Angelica Kohlmann and Christoph Mäder will not stand for re-election, the company said in its September 30 announcement.

The nomination extends a board renewal process that has added eight new members since 2024. Huang brings experience from Roche, GSK, Merck, Waters Corporation and BB Biotech, giving the change a clear pharmaceutical and biotechnology angle.

Half-year sales reached CHF 3.4 billion

Lonza generated sales of CHF 3.4 billion and CORE EBITDA of CHF 1.2 billion in Half-Year 2026, figures carried in the company information published by Markets Insider. The latest standardized financial data show quarterly revenue of CHF 3.45 billion and net income of CHF 603.7 million for the quarter ended June 30, 2026.

That quarterly revenue compares with CHF 2.96 billion in the prior period shown in the financial series, while operating income reached CHF 822.3 million in the quarter ended June 30, 2026. For investors, the combination of board expertise and profitable growth keeps execution and capital allocation at the center of the Lonza story.

Barclays keeps a CHF 730.00 target

Barclays maintained a Buy rating and a CHF 730.00 price target on September 24, 2026, according to Markets Insider. The same report cited a consensus target of CHF 705.43, while Lonza's SIX listing reached a 52-week high of CHF 597.80 on August 25, 2026.

Lonza stock rises after Xetra close

At Lang & Schwarz, Lonza Group stock was trading at EUR 606.70 on October 2, 2026 at 5:02 p.m. CEST, after the Xetra close. The price was up EUR 7.40, or 1.23 percent, against the Lang & Schwarz prior close of EUR 599.30 on October 1, 2026. The further course of trading is shown by the continuously updated real-time quote of Lonza Group stock.